Scientists from Harvard University & Mayo Clinic validate our ionic liquid platform

  • Home
    • Board of Directors
    • Scientific Advisory Board
    • Partnerships
  • Our Technology
    • Our Team
    • Career
    • Press Releases
    • In the news
    • Publications
  • Contact Us
    • Home
    • About Us
      • Board of Directors
      • Scientific Advisory Board
      • Partnerships
    • Our Technology
    • People
      • Our Team
      • Career
    • Media
      • Press Releases
      • In the news
      • Publications
    • Contact Us
  • Home
  • Our Technology
  • Contact Us
image285

The Ionic Liquid platform

Our IL Platform uses structural heterogeneity of cations & anions to enhance membrane permeation

We have demonstrated delivery of a wide range of materials including small molecules, peptides, proteins and nucleic acids across the stratum corneum following topical administration with minimal impact on barrier functions and viability. This unprecedented flexibility in the choice of cations and anions enables us to engineer diverse ILs with tailor‐made properties for multiple therapeutic areas. 

 

Additionally, the inherent properties of such deep eutectic ILs as broad-spectrum antimicrobial agents in addition to exceptional solvation and permeation enhancement offer phenomenal opportunities in drug discovery and pharmaceutical space. 

What is an Ionic Liquid?

An ionic liquid (IL) is a salt in which the ions are poorly coordinated, which results in these solvents being liquid below 100°C, or even at room temperature (room temperature ionic liquids, RTIL's). 


Find out more

Copyright © 2020 CAGE Bio Inc. - All Rights Reserved.


This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept
image286

Welcome! Check out our latest news.

Scientists from Harvard University and Mayo Clinic validate our ionic liquid platform for treating large hepatocellular tumors to help bridge more patients to liver transplantation. 

Learn more